Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Sep-Oct;8(5):113-7.
doi: 10.1111/j.1535-7511.2008.00261.x.

Generic antiepileptic drugs: current controversies and future directions

Michael D Privitera  1
Affiliations

Generic antiepileptic drugs: current controversies and future directions

Michael D Privitera. Epilepsy Curr. 2008 Sep-Oct.

Abstract

The Food and Drug Administration requires rigorous testing of generic formulations of antiepileptic drugs to assure bioequivalence to the brand product and asserts that all approved formulations are interchangeable. Physician surveys, case reports, and "switchback" rates from large-scale generic conversions imply that all generic formulations may not be equal to the brand drug for all patient groups. This review presents the current state of the data on bioequivalence and therapeutic equivalence and proposes a series of studies to better clarify the risks of generic formulation substitution in susceptible populations. Until such studies are completed, when switching to generic formulations, health-care providers and people with epilepsy would do well to proceed cautiously and understand the potential risks and benefits of substitution. Extra caution may be needed for patients at highest risk of seizure complications, such as the pregnant patient, patients with recurrent status epilepticus, or patients who have been seizure-free for long periods of time and are driving.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
NDA versus ANDA review process.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Savings with generic drugs. Available at http://www.fda.gov/cder/ogd/02-10_BCBS_gjb/sld003.htm Accessed 3/31/2008.
    1. Liow K, Barkley GL, Pollard JR, Harden CL, Bazil CW, The American Academy of Neurology Position statement on the coverage of anticonvulsant drugs for the treatment of epilepsy. Neurology. 2007;68:1249–1250. - PubMed
    1. Rubenstein S. Industry fights switch to generics for epilepsy. Wall Street Journal. July 2007;13:A1–A10.
    1. Henney JE. From the food and drug administration. JAMA. 1999;282 1995. - PubMed
    1. NDA vs. ANDA Review Process. [3/31/2008]. Available at http://www.fda.gov/cder/ogd/02-10_BCBS_gjb/sld009.htm.